ImmuneOnco Biopharmaceuticals (Shanghai) Goodwill

As of the most recent data (June 2026), 1541.HK shows a goodwill of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1541.HK's goodwill is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether ImmuneOnco Biopharmaceuticals (Shanghai) is outperforming or lagging.

Tracking 1541.HK's goodwill over time shows whether ImmuneOnco Biopharmaceuticals (Shanghai) is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has ImmuneOnco Biopharmaceuticals (Shanghai)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

ImmuneOnco Biopharmaceuticals (Shanghai)'s goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.